Large Cap Healthcare
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
101
State Street SPDR S&P Biotech ETF
XBI
$10.6B
| $10.6B | $156.31 | 0.81% |
|
102
Insulet
PODD
$10.4B
| $10.4B | $150.03 | 1.33% |
|
103
Qiagen
QGEN
$10.4B
| $10.4B | $50.30 | 0.42% |
|
104
Bio-Rad Laboratories Class A
BIO
$10.4B
| $10.4B | $386 | 0.12% |
|
105
Spyre Therapeutics
SYRE
$10.1B
| $10.1B | $106.82 | 2.24% |
|
106
TG Therapeutics
TGTX
$10.1B
| $10.1B | $65.76 | 2.33% |
|
107
Madrigal Pharmaceuticals
MDGL
$10.1B
| $10.1B | $433.03 | 0.1% |
|
108
Globus Medical
GMED
$10B
| $10B | $75.39 | 0.21% |
|
Large Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 108 large cap Healthcare stocks — companies in the Healthcare sector with a market cap between $10B and $200B — worth a combined $4.7T.
The largest by market cap are Abbott (ABT) at $189B, Novo Nordisk (NVO) at $181B and Pfizer (PFE) at $168B.
Among institutional investors, CVS Health (CVS) drew the most net new fund positions in Q2 2026: 326 funds opened new positions, taking total fund holders up 198 (10%) quarter-over-quarter.
- Combined market cap: $4.7T across 108 stocks.
- Large Cap: market cap between $10B and $200B.
- Largest constituent: Abbott (ABT), $189B market cap.
- Most net new fund positions in Q2 2026: CVS Health (CVS), +198 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.